pharma · Advanced Cancer · Non-small Cell Lung Cancer · RCUS
Arcus Biosciences
Arcus Biosciences clinical programs — 10 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 3928 Point Eden Way, Hayward, California 94545, US
- Founded
- 2015
- Employees
- 655
- Programs
- 53
- Drugs
- 25
- Patents
- 30
Arcus Biosciences projects
10 ClinicalTrials.gov programs sponsored by Arcus Biosciences.
Arcus Biosciences has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ARC-10
Arcus Biosciences
Squamous Non-small cell Lung Cancer, Non-Small Cell Lung Cancer, Non squamous Non Small Cell Lung Cancer, Lung Cancer
1 trial -
Casdatifan
Arcus Biosciences
Metastatic Clear Cell Renal Cell Carcinoma
1 trial -
Domvanalimab
Arcus Biosciences
Advanced Upper Gastrointestinal Tract Adenocarcinoma
1 trial -
Durvalumab
Arcus Biosciences
Non-Small Cell Lung Cancer
1 trial -
PEAK-1
Arcus Biosciences
Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
1 trial -
PRISM-1
Arcus Biosciences
Pancreatic cancer, Metastatic Pancreatic ductal adenocarcinoma (mPDAC), Pancreatic ductal adenocarcinoma (PDAC)
1 trial -
Quemliclustat
Arcus Biosciences
Metastatic Pancreatic Ductal Adenocarcinoma
1 trial -
STAR-221
Arcus Biosciences
Metastatic Esophageal or Gastric Cancer, Esophageal or Gastric Cancer
1 trial -
Volrustomig
Arcus Biosciences
Advanced Clear Cell Renal Cell Carcinoma
1 trial -
Zimberelimab
Arcus Biosciences
Non-small Cell Lung Cancer
2 trials
Frequently asked questions
How many clinical projects does Arcus Biosciences have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.